Colonoscopies
are secure and have been proven to be a successful way to screen for colon
cancer. In any case, a few patients cannot endure the procedure, or may be at
higher risk for sedation. During a standard colonoscope, a flexible tube
(colonoscope) is embedded into the rectum and guided by a physician through the
colon. A camera at the end of the colonoscope allows for visualization of
polyps which, in case left in place, can turn into cancer. The polyps are
evacuated during the procedure. Patients are sedated and require to take a day
off from their normal activities.
A new non-invasive and most recent alternative to this has been
developed in which the system can help distinguish growths called polyps, like
a colonoscopy. The patient ingests PillCam™ Colon 2, a capsule containing two
miniature cameras on the either end. It captures pictures as the capsule
descends the digestive tract and wirelessly transmits them to a recorder which
the patient wears on a belt. Introducing the new structure, the patient has to
gulp the capsule with water after which the non-reusable capsule is excreted,
it's flushed down the toilet. The patient returns the recorder to the
physician's office. In case a polyp is found, the patient arranges to
experience a colonoscopy to evacuate the growth.
A patient who undergoes the capsule technique has
to go through the same bowel-cleansing activity as a patient undergoing a
colonoscopy. But unlike a standard colonoscopy, the pill capsule system is
painless and requires no anaesthesia. Patients do not have to take a day off
work or arrange someone to drive them to and from the test. Colorectal cancer is
the third-leading cause of cancer deaths in women and second leading cause in
men. Early detection and screening are essential to lessen the rates of
colorectal cancer. Primary detection has been confirmed to save lives, in
addition to the video capsule system also offers an appropriate screening test
for people who are unable to have a complete colonoscopy.
17th International
Conference
on Gastroenterology and Hepatology provides an unparalleled platform for
young minds and researchers to talk over latest technology and research, which
is slated on September 03-04, 2018 in Dubai, UAE.
For more details, visit the below link:
https://gastrocongress.conferenceseries.com/
Contact:
Anna
Harper
Program
Manager
World
Gastroenterology 2018
Email: hepatologymeet@gastroconferences.com
